Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-10-27 to 2022-11-18
Current total value of award: $4534.08
Description: 4558920690!OMIDRIA 1-0.3% VIAL 4ML